Skip to content

Evaluation of La Roche-Posay's self-controlled clinical observation study for the relief of skin sensitivity with medical wound dressings

Evaluation of La Roche-Posay's self-controlled clinical observation study for the relief of skin sensitivity with medical wound dressings

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500103355
Enrollment
Unknown
Registered
2025-05-28
Start date
2022-09-09
Completion date
Unknown
Last updated
2025-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin sensitivity

Interventions

Observation group:The subjects used hyaluronic acid dressing once every other day in the first 14 days (1, 3, 5, 7, 9, 11, and 13d), and the dressing was applied once every two days for the next 14 da

Sponsors

Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Science &Peking Union
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: (1) Aged 18-55 years old, meeting the diagnostic criteria of Chinese expert consensus on the diagnosis and treatment of sensitive skin (2) Patients who volunteered to participate in this study and signed informed consent

Exclusion criteria

Exclusion criteria: (1) those who are known to be allergic to any ingredient in the product or who have an allergic constitution; (2) patients with facial skin that may affect the efficacy evaluation, such as solar dermatitis, seborrheic dermatitis, eczema, etc.; (3) severe history of heart disease, liver and kidney diseases, hypertension; (4) patients with severe endocrine diseases, hematological diseases, and neuropsychiatric diseases; (5) pregnant and lactating women; (6) patients who were deemed by the investigator to be ineligible for other reasons.

Design outcomes

Primary

MeasureTime frame
The stratum corneum water content;Transepidermal water loss (TEWL);VISIA-CR Facial Imaging Analysis;Sensitive of Skin;

Countries

China

Contacts

Public ContactBeibei Zhu

Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Science &Peking Union

zbb19850729@126.com+86 189 5164 1082

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026